Early Lung Cancer Diagnosis in HIV Infected Population With an Important Smoking History With Low Dose CT: a Pilot Study
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2010-09-23
- Last Posted Date
- 2015-07-20
- Lead Sponsor
- ANRS, Emerging Infectious Diseases
- Target Recruit Count
- 450
- Registration Number
- NCT01207986
- Locations
- 🇫🇷
Makinson, Montpellier, France
A Randomized Study to Assess the Loss of HbsAg After a 48-week Treatment Period With Pegylated Interferon Alpha 2a in Patients With Chronic Hepatitis B
Phase 3
- Conditions
- Interventions
- First Posted Date
- 2010-07-29
- Last Posted Date
- 2013-03-29
- Lead Sponsor
- ANRS, Emerging Infectious Diseases
- Target Recruit Count
- 185
- Registration Number
- NCT01172392
- Locations
- 🇫🇷
Hôpital Saint Joseph, Service d'hépatogastroentérologie, Marseille, France
Cohort of HIV Associated Lymphomas
Completed
- Conditions
- First Posted Date
- 2010-07-16
- Last Posted Date
- 2017-11-06
- Lead Sponsor
- ANRS, Emerging Infectious Diseases
- Target Recruit Count
- 205
- Registration Number
- NCT01164436
- Locations
- 🇫🇷
BESSON, Paris, France
Evaluation of Simplified Antiretroviral Treatment Strategies in HIV Infected Children Treated by Antiretroviral (ARV) Before One Year of Age
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2010-05-20
- Last Posted Date
- 2016-07-12
- Lead Sponsor
- ANRS, Emerging Infectious Diseases
- Target Recruit Count
- 161
- Registration Number
- NCT01127204
- Locations
- 🇧🇫
Service de pédiatrie - CHU Yalgado Ouedraogo, Ouagadougou, Burkina Faso
🇨🇮CEPREF, Abidjan, Côte D'Ivoire
🇨🇮FSU abobo-Avocatier, Abidjan, Côte D'Ivoire
Study of Darunavir/r + Tenofovir/Emtricitabine vs. Darunavir/r + Raltegravir in HIV-infected Antiretroviral naïve Subjects
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2010-02-10
- Last Posted Date
- 2013-11-06
- Lead Sponsor
- ANRS, Emerging Infectious Diseases
- Target Recruit Count
- 800
- Registration Number
- NCT01066962
- Locations
- 🇮🇹
Torvergata University, Rome, Italy
🇪🇸Hospital Clinic, Barcelona, Spain
🇮🇹University of Brescia, Brescia, Italy
Optimisation of Primary HIV1 Infection Treatment(ANRS 147 OPTIPRIM)
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-12-16
- Last Posted Date
- 2014-02-05
- Lead Sponsor
- ANRS, Emerging Infectious Diseases
- Target Recruit Count
- 90
- Registration Number
- NCT01033760
- Locations
- 🇫🇷
Hôpital Gustave Dron, Tourcoing, France
Raltegravir in Patients With End Stage Liver Disease and in Transplant Recipients
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-12-01
- Last Posted Date
- 2013-07-18
- Lead Sponsor
- ANRS, Emerging Infectious Diseases
- Target Recruit Count
- 14
- Registration Number
- NCT01022476
- Locations
- 🇫🇷
Service de Médecine Interne, Hôpital de Bicêtre, LE KREMLIN-BICETRE cedex, France
Study Comparing the Tolerability and Viral Reduction of the Combination of IFN a-2b XL + Ribavirin Versus Peg IFN a-2b + Ribavirin in Patients With Chronic Hepatitis C, Genotype 1 or 4
- First Posted Date
- 2009-11-10
- Last Posted Date
- 2013-09-20
- Lead Sponsor
- ANRS, Emerging Infectious Diseases
- Target Recruit Count
- 84
- Registration Number
- NCT01010646
- Locations
- 🇫🇷
Hôpital de la Croix Rousse, Lyon, France
Evaluation of Three Strategies of Second-line Antiretroviral Treatment in Africa (Dakar - Bobo-Dioulasso - Yaoundé)
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-06-25
- Last Posted Date
- 2017-02-27
- Lead Sponsor
- ANRS, Emerging Infectious Diseases
- Target Recruit Count
- 454
- Registration Number
- NCT00928187
- Locations
- 🇧🇫
Day Hospital, CHU Sanou Souro, Bobo Dioulasso, Burkina Faso
🇨🇲Day Hospital, Central Hospital, Yaounde, Cameroon
🇸🇳Clinical Research and Training Center, Fann Hospital, Dakar, Senegal
Efficacy and Safety of Varenicline Among HIV-infected Patients
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-06-11
- Last Posted Date
- 2014-07-29
- Lead Sponsor
- ANRS, Emerging Infectious Diseases
- Target Recruit Count
- 248
- Registration Number
- NCT00918307
- Locations
- 🇫🇷
CHU de Bordeaux, Bordeaux, France
© Copyright 2024. All Rights Reserved by MedPath